Back to Clinical Trials Overview

Your search for "Vascular" returned 37 results:


A Prospective , Single Blind, Randomized, Multi-Center, Study Comparing the Cypher-ELITE to Cypher Bx VELOCITY Sirolimus-Eluting Stent Systems (ELITE Study)
Principal Investigator(s): Moreno, Pedro

A Prospective, Two-Arm, Open-Label, Multi-Center Registry using XIENCE PRIME EECSS and XIENCE PRIME LL EECSS (SPIRIT-PRIME)
Principal Investigator(s): Sharma, Samin

Cardiovascular Outcomes in Renal Atherosclerotc Lesions
Principal Investigator(s): Olin, Jeffrey W.

JOSTENT Coronary Stent Graft
Principal Investigator(s): Sharma, Samin

XIENCE V Everolimus Eluting Coronary Stent System (EECSS) USA Post-Approval Study
Principal Investigator(s): Sharma, Samin

Genetic Determinants of Pheripheral arterial disease
Principal Investigator(s): Olin, Jeffrey W.

A Clinical Evaluation of the Medtronic Endeavor Resolute Zotarolimus-Eluting Coronary Stent System in the Treatment of De Novo Lesions in Native Coronary Arteries with a Reference Vessel Diameter of 2.25 mm to 4.2 mm
Principal Investigator(s): Kim, Michael

Endurant Stent Graft System US Clinical Study
Principal Investigator(s): Ellozy, Sharif

Aneurysm Treatment using the HeliFX™ Aortic Securement System Global Registry (ANCHOR Registry)
Principal Investigator(s): Sharif Ellozy

A Prospective, non-randomized, multi-center, clinical trial to evaluate the safety and efficacy of the Absolute Pro Peripheral self-expanding stent system in subjects with atherosclerotic de novo or restenotic lesions in the the native common iliac artery and/or native external iliac artery. (MOBILITY)
Principal Investigator(s): Krishnan, Prakash

Prevent Return of Stroke
Principal Investigator(s): Carol Horowitz

Endothelial Function in Fibromuscular Dysplasia
Principal Investigator(s): Olin, Jeffrey W.

A Prospective Randomized Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS element) for the Treatment of up to Two De Novo Coronary Artery Lesions - PLATINUM Trial
Principal Investigator(s): Kini, Annapoorna

A Randomized Open-Label Parallel-Group Multi-Center Study of Adding Edoxaban or Clopidogrel to Aspirin to Maintain Patency in Subjects with Peripheral Arterial Disease Following Femoropopliteal Endovascular Intervention- Edoxaban in Peripheral Arterial Disease (EPAD)
Principal Investigator(s): Ageliki Vouyouka

Hypothyroidism and The Risk of Peripheral Vascular Disease
Principal Investigator(s): Mazzeffi, Michael

Effect of VIA-2291 on Vascular Inflammation after ACS
Principal Investigator(s): Farkouh, Michael E.

A Prospective Multicenter Single Blind Randomized Controlled Trial Comparing the Lutonix Drug Coated Balloon vs. Standard Balloon Angioplasty for Treatment of Below-the-Knee (BTK) Arteries
Principal Investigator(s): Rami Tadros

Durability Iliac
Principal Investigator(s): Rajesh Malik

A Randomized, Open Label, Investigator-Initiated Trial comparing Intravascular Ultrasound-Guided Atherectomy to Angiography-Guided Atherectomy in Peripheral Vascular Interventions for TASC's A, B, C lesions. (UTOPIA trial)
Principal Investigator(s): Prakash Krishnan

Fibromuscular dysplasia international society registry
Principal Investigator(s): Olin, Jeffrey W.

The Cardiac Benefit of Androgen Replacement in Hypogonadal Males with Coronary Artery Disease Following Successful Percutaneous Coronary Intervention (PCI)
Principal Investigator(s): McLaughlin, Mary A

Chronometric Observations of Lipid Core Containing Plaques of Interest in Native Coronary Arteries Registry (COLOR Registry)
Principal Investigator(s): Kim, Michael

Assessment of a Non-Contrast MRA Technique in Comparison with Contrast-Enhanced MRA of Abdominal Vasculature
Principal Investigator(s): Lookstein, Robert

A Prospective, multi-center, randomized controlled trial of the IMPELLA RECOVER LP 2.5 System versus Intra Aortic Balloon Pump (IABP) in Patients Undergoing Non Emergent High Risk PCI [Protect II]
Principal Investigator(s): Sharma, Samin

A 12-Week, Randomized, Semi Double-Blinded Study Evaluating the Effects of Daily Oral High-Dose Atorvastatin or BMS-582949 on Atherosclerotic Plaque Inflammation as Determined by FDG-PET in High Risk Atherosclerotic Patients
Principal Investigator(s): Fayad, Zahi A

Trial of Epic Nitinol Stent System in the Treatment of Athersclerotic Lesions in Iiac Arteries
Principal Investigator(s): Lookstein, Robert

COSTAR II Trial
Principal Investigator(s): Sharma, Samin

A Prospective, Single Blind, Randomized Controlled Study to Evaluate the Safety And Effectiveness of the Tryton Side Branch Stent™ used in Conjunction with a Drug-Eluting Stent Compared to Side Branch Balloon Angioplasty in Conjunction with a Drug-Eluting Stent in the Treatment of de novo Bifurcation Lesions Involving the Main Branch and Side Branch within the Native Coronary Circulation (TRYTON side-branch stent TRIAL)
Principal Investigator(s): Samin Sharma, MD

CObalt chromium STent with Antiproliferation for Restenosis II Trial
Principal Investigator(s): Samin K. Sharma, MD

Surgical Interventions for Moderate Ischemic Mitral Regurgitation
Principal Investigator(s): Ascheim, Deborah

Effects of High Dose Statin Therapy (FDG)/Atheroscleroti
Principal Investigator(s): Farkouh, Michael E.

A Randomized Multicenter Clinical Trial of Unruptured Brain Arteriovenous malformations (ARUBA)
Principal Investigator(s): Moskowitz, Alan

A multi-center, randomized, double blind, placebo-controlled, study of the safety, tolerability, and effects on arterial structure and function of ACZ885 (canakinumab) in patients with clinically evident atherosclerosis and either type 2 diabetes mellitus (T2DM) or impaired glucose tolerance (IGT)
Principal Investigator(s): Fayad, Zahi A

Effect of Particulate Matter Exposure on Carotid Plaque Neovascularization Using Dynamic Contrast Enhances Magnetic Resonance Imaging
Principal Investigator(s): McLaughlin, Mary A

A Multicenter, Open Label, Prospective, Non-Randomized Study of the Incraft Stent Graft System in Subjects with Abdominal Aortic Aneurysms
Principal Investigator(s): Peter Faries

Coronary Revascularization in Diabetic Patients [FREEDOM TRIAL]
Principal Investigator(s): Fuster, Valentin

Future Revascularization Evaluation in Patients with Diabetes Mellitus:Optimal Management of Multivessel Disease (FREEDOM Trial)
Principal Investigator(s): Sharma, Samin